Paper35106919
Patterns of the use of advanced radiation therapy techniques for the management of bone metastases and the associated factors in Victoria.
Fogarty T and 8 others. J Med Imaging Radiat Oncol, 2022. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Patterns of the use of advanced radiation therapy techniques for the management of bone metastases and the associated factors in Victoria. Papers, record 35106919. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35106919
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Patterns of the use of advanced radiation therapy techniques for the management of bone metastases and the associated factors in Victoria.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Radiosurgery | Major topic |
| Radiotherapy, Intensity-Modulated | Major topic |
| Spinal Neoplasms | Major topic |
| Aged | |
| Humans | |
| Male | |
| Medicare | |
| Radiotherapy Dosage | |
| Radiotherapy Planning, Computer-Assisted | |
| United States |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Council of Australian University Librarians | PubMed | |||
| Monash University | PubMed |
Source PubMed
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31734589 | Stereotactic ablative body radiotherapy (SABR) for bone only oligometastatic breast cancer: A prospective clinical trial. | Breast | 2020 | https://conductscience.org/library/papers/31734589 | PubMed |
| 2 | 30061275 | Quality of Life and Radiation-induced Late Toxicity Following Intensity-modulated Versus Three-dimensional Conformal Radiotherapy for Patients with Spinal Bone Metastases: Results of a Randomized Trial. | Anticancer Res | 2018 | https://conductscience.org/library/papers/30061275 | PubMed |
| 3 | 33217497 | Patterns of use of palliative radiotherapy fractionation for bone metastases and 30-day mortality. | Radiother Oncol | 2021 | https://conductscience.org/library/papers/33217497 | PubMed |
| 4 | 17416863 | Palliative radiotherapy trials for bone metastases: a systematic review. | J Clin Oncol | 2007 | https://conductscience.org/library/papers/17416863 | PubMed |
| 5 | 32114269 | Single fraction radiosurgery, fractionated radiosurgery, and conventional radiotherapy for spinal oligometastasis (SAFFRON): A systematic review and meta-analysis. | Radiother Oncol | 2020 | https://conductscience.org/library/papers/32114269 | PubMed |
| 6 | 29843899 | Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy. | Radiother Oncol | 2018 | https://conductscience.org/library/papers/29843899 | PubMed |
| 7 | 31505246 | Variation in the Use of Single- Versus Multifraction Palliative Radiation Therapy for Bone Metastases in Australia. | Int J Radiat Oncol Biol Phys | 2020 | https://conductscience.org/library/papers/31505246 | PubMed |
| 8 | 30227924 | Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial. | Eur Urol | 2018 | https://conductscience.org/library/papers/30227924 | PubMed |
| 9 | 22673744 | Intensity-modulated radiotherapy in the treatment of prostate cancer. | Clin Oncol (R Coll Radiol) | 2012 | https://conductscience.org/library/papers/22673744 | PubMed |
| 10 | 29978307 | Radiation-induced acute toxicities after image-guided intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for patients with spinal metastases (IRON-1 trial) : First results of a randomized controlled trial. | Strahlenther Onkol | 2018 | https://conductscience.org/library/papers/29978307 | PubMed |
| 11 | 30849005 | Trends in Radiation for Bone Metastasis During a Period of Multiple National Quality Improvement Initiatives. | J Oncol Pract | 2019 | https://conductscience.org/library/papers/30849005 | PubMed |
| 12 | 25345713 | Trans Tasman Radiation Oncology Group: Development of the Assessment of New Radiation Oncology Technology and Treatments (ANROTAT) Framework. | J Med Imaging Radiat Oncol | 2015 | https://conductscience.org/library/papers/25345713 | PubMed |
| 13 | 26229674 | Dose planning objectives in anal canal cancer IMRT: the TROG ANROTAT experience. | J Med Radiat Sci | 2015 | https://conductscience.org/library/papers/26229674 | PubMed |
| 14 | 26439588 | Testing the Assessment of New Radiation Oncology Technology and Treatments framework using the evaluation of post-prostatectomy radiotherapy techniques. | J Med Imaging Radiat Oncol | 2016 | https://conductscience.org/library/papers/26439588 | PubMed |
| 15 | 31021390 | Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases: A Randomized Phase 2 Trial. | JAMA Oncol | 2019 | https://conductscience.org/library/papers/31021390 | PubMed |
| 16 | 33333200 | Pain Response After Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Patients With Bone Metastases-A Phase 2 Randomized Controlled Trial Within a Prospective Cohort. | Int J Radiat Oncol Biol Phys | 2021 | https://conductscience.org/library/papers/33333200 | PubMed |
| 17 | 30770291 | Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial. | Lancet Oncol | 2019 | https://conductscience.org/library/papers/30770291 | PubMed |
| 18 | 33309977 | Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of the SABR-COMET Randomized Trial. | Int J Radiat Oncol Biol Phys | 2021 | https://conductscience.org/library/papers/33309977 | PubMed |
| 19 | 34126044 | Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial. | Lancet Oncol | 2021 | https://conductscience.org/library/papers/34126044 | PubMed |
| 20 | 32584700 | Advanced Radiation Therapy Technology Use in the Treatment of Bone Metastases in a Public, Salary-Funded, Non-Incentivized Health Care System. | JCO Oncol Pract | 2021 | https://conductscience.org/library/papers/32584700 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37623045 | Stereotactic Body Radiation Therapy for Spine Metastases-Findings from an Australian Population-Based Study. | Curr Oncol | 2023 | https://conductscience.org/library/papers/37623045 | PubMed |
| 35599450 | Large variation in radiation therapy fractionation for multiple myeloma in Australia. | Asia Pac J Clin Oncol | 2023 | https://conductscience.org/library/papers/35599450 | PubMed |
| 35323367 | Evaluation of Patient-Reported Outcome Differences by Radiotherapy Techniques for Bone Metastases in A Population-Based Healthcare System. | Curr Oncol | 2022 | https://conductscience.org/library/papers/35323367 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35106919
GET https://conductscience.org/api/papers/v1/35106919/references?page=2